An interventional study of Apple Software and by Audiologist in Hearing, sponsored by Apple Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-29.
Sponsored by Apple Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Validation of non-inferiority between headphone amplification settings determined by a participant and settings established by audiologist best practices in individuals 18 years or older.
Apple Inc. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Amplification settings established by algorithm and further adjusted by participants per their preference
Device: Apple Software
Amplification settings established by clinical reference and further adjusted by an audiologist per current best practice
Device: by Audiologist
Amplification settings established by algorithm and further adjusted by participants per their preference
Amplification settings established by clinical reference and further adjusted by an audiologist per current best practice
International Outcome Inventory for Hearing Aids (IOI-HA) Survey Results
The IOI-HA survey is a 7-item questionnaire that assesses the effectiveness of hearing aids. It was self-administered to each study participant one time at the third scheduled clinic visit approximately 18-31 days after enrollment. For each participant, the IOI-HA total score (which ranges from 7-35 where higher scores indicate a better outcome) was computed and the mean IOI-HA scores were compared between the Experimental and Reference Groups.
Time frame: Approximately 18-31 days upon enrollment
Participants were recruited from multiple sites where audiological services were provided.
| Milestone | Self-Fit Settings | Pro-Fit Settings |
|---|---|---|
| Started | 59 | 59 |
| Completed | 59 | 59 |
| Not completed | 0 | 0 |
The IOI-HA survey is a 7-item questionnaire that assesses the effectiveness of hearing aids. It was self-administered to each study participant one time at the third scheduled clinic visit approximately 18-31 days after enrollment. For each participant, the IOI-HA total score (which ranges from 7-35 where higher scores indicate a better outcome) was computed and the mean IOI-HA scores were compared between the Experimental and Reference Groups.
| score on a scale | Self-Fit Settings | Pro-Fit Settings |
|---|---|---|
| International Outcome Inventory for Hearing Aids (IOI-HA) Survey Results | 25.5 ± 3.03 | 26.6 ± 3.63 |
Collected over Participants were evaluated by the PI and/or designee(s) at each of the three scheduled clinic visits from the time they signed the ICF until they completed the study (approximately 18-31 days after enrollment).. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Self-Fit Settings | 0/59 (0%) | 0/59 (0%) | 0/59 (0%) |
| Pro-Fit Settings | 0/59 (0%) | 1/59 (1.7%) | 0/59 (0%) |
| Event | Self-Fit Settings | Pro-Fit Settings |
|---|---|---|
| Chest PainGeneral disorders | 0/59 | 1/59 |
| Pain in ExtremityMusculoskeletal and connective tissue disorders | 0/59 | 1/59 |
| Age, Categorical(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 33 | 35 | 68 |
| >=65 years | 26 | 24 | 50 |
| Sex: Female, Male(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| Female | 30 | 39 | 69 |
| Male | 29 | 20 | 49 |
| Ethnicity (NIH/OMB)(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 1 | 2 |
| Not Hispanic or Latino | 58 | 58 | 116 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 0 | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 4 | 10 | 14 |
| White | 53 | 48 | 101 |
| More than one race | 0 | 1 | 1 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Region of Enrollment(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| United States | 59 | 59 | 118 |
| Subject Medical History with >10.0% Occurrence(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| Deafness bilateral | 26 | 23 | 49 |
| Hypertension | 10 | 12 | 22 |
| Hypoacusis | 5 | 6 | 11 |
| Tinnitus | 14 | 4 | 18 |
| Four-Frequency Pure Tone Average Results-Full Analysis Set(Participants) | Self-Fit Settings | Pro-Fit Settings | Total |
|---|---|---|---|
| 15-25 dB HL (No Impairment) | 12 | 15 | 27 |
| 26-40 dB HL (Mild Impairment) | 26 | 26 | 52 |
| 41-60 dB HL (Moderate Impairment) | 21 | 18 | 39 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Apr 2023 to primary completion in Aug 2023, 3 months.
Results were first posted in Oct 2024, 1 year 2 months after primary completion. A results delay was requested in Aug 2024.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Apple Inc.